Pediatr Nephrol (2008) 23:527–535 70. Reaich D, Channon SM, Scrimgeour CM, Goodship TH (1992) Ammonium chloride-induced acidosis increases protein break- down and amino acid oxidation in humans. Am J Physiol 263: E735–E739 71. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R (1995) Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39–45 72. Papadoyannakis NJ, Stefanidis CJ, McGeown M (1984) The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure. Am J Clin Nutr 40:623–627 73. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship TH (1993) Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265:E230–E235 74. Garibotto G, Russo R, Sofia A, Sala MR, Robaudo C, Moscatelli P, DeFerrari G, Tizianello A (1994) Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 45:1432–1439 75. Williams B, Hattersley J, Layward E, Walls J (1991) Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 40:779–786 76. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH (1997) Correction of acidosis in hemodialysis decreases whole- body protein degradation. J Am Soc Nephrol 8:632–637 77. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Cancarini GC, Scolari F, Feller P, Maiorca R (1998) Correction of metabolic acidosis increases serum albumin concentration and decreases kinetically evaluated protein intake in hemodialysis patients: A prospective study. Nephrol Dial Transplant 13:1719–1722 78. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, Goodship TH (1996) Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396–1400 79. Stein A, Moorhouse J, Iles-Smith H, Baker R, Johnstone J, James G, Troughton J, Bircher G, Walls J (1997) Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089–1095 535 80. Challa A, Krieg RJ, Thabet MA, Veldhuis JD, Chan JC (1993) Metabolic acidosis inhibits growth hormone secretion in rats: mechanism of growth retardation. Am J Physiol 265: E547–E553 81. Brungger M, Hulter HN, Krapf R (1997) Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans. Kidney Int 51:216–221 82. Wiederkehr MR, Kalogiros J, Krapf R (2004). Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 19:1190–1197 83. Kuemmerle N, Krieg RJ, Latta K, Challa A, Hanna JD, Chan JC (1997) Growth hormone and insulin-like growth factor in non- uremic acidosis and uremic acidosis. Kidney Int 58:S102–S105 84. Green J, Maor G (2002) Effect of metabolic acidosis on the growth hormone/IGF-1 endocrine axis in skeletal growth centers. Kidney Int 57:2258–2267 85. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45:275–280 86. Mak RH (1998) Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54:603–607 87. Bereket A, Wilson TA, Kolasa AJ, Fan J, Lang CH (1996) Regulation of the insulin-like growth factor system by acute acidosis. Endocrinology 137:2238–2245 88. Brungger M, Hulter HN, Krapf R (1997) Effect of chronic metabolic acidosis on thyroid hormone homeostasis in humans. Am J Physiol 272:F648–F653 89. Schambelan M, Sebastian A, Katuna A, Arteaga E (2001) Adrenocortical hormone secretory response to chronic NH4Cl- induced metabolic acidosis. Am J Physiol 252:E454–E460 90. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH (1997) Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 8:627–631 91. Krapf R, Vetsch R, Vetsch W, Hulter HN (1992) Chronic metabolic acidosis increases the serum concentration of 1,25- dihydroxyvitamin D in humans by stimulating its production rate. J Clin Invest 90:2456–2463